A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
复制标题
DOI：
10.1093/europace/euv304
复制
发表时间：
2016-01-01
期刊：
影响因子：
6.1
通讯作者：
Camm, A. John
中科院分区：
文献类型：
--
作者：
Kirchhof, Paulus;Breithardt, Guenter;Camm, A. John
全世界至少有3000万人被诊断患有心房颤动（AF），并且更多的人患有未诊断的、亚临床的或“沉默的”AF。心房颤动相关的心血管死亡率和发病率，包括心血管死亡、心力衰竭、中风和住院治疗，仍然高得不可接受，即使使用基于证据的治疗，例如抗凝和心率控制。此外，仍然有必要确定如何最好地预防AF，主要是由于缺乏临床措施，可以识别任何给定患者的AF可治疗原因。因此，在AF患者的评估和管理方面存在重要的未满足的临床和研究需求。2015年1月22日和23日在法国尼斯举行的第五届房颤网络/欧洲心律协会共识会议上讨论了提高房颤护理质量的后续需求和机会。在这里，我们报告本次会议的成果，重点是（i）从我们的“邻居”学习，以改善AF护理，（ii）以患者为中心的AF管理方法，（iii）AF患者的结构化护理，（iv）提高AF治疗的质量，（v）AF管理的个性化。本报告最后列出了房颤患者研究的优先事项。
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more suffer from undiagnosed, subclinical, or 'silent' AF. Atrial fibrillation-related cardiovascular mortality and morbidity, including cardiovascular deaths, heart failure, stroke, and hospitalizations, remain unacceptably high, even when evidence-based therapies such as anticoagulation and rate control are used. Furthermore, it is still necessary to define how best to prevent AF, largely due to a lack of clinical measures that would allow identification of treatable causes of AF in any given patient. Hence, there are important unmet clinical and research needs in the evaluation and management of AF patients. The ensuing needs and opportunities for improving the quality of AF care were discussed during the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference in Nice, France, on 22 and 23 January 2015. Here, we report the outcome of this conference, with a focus on (i) learning from our 'neighbours' to improve AF care, (ii) patient-centred approaches to AF management, (iii) structured care of AF patients, (iv) improving the quality of AF treatment, and (v) personalization of AF management. This report ends with a list of priorities for research in AF patients.